INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 4 Jul · 19:14 IST

Ind-Swift Laboratories Limited has informed the Exchange about re-constitution of various committees of the Board of the Company

Management Changes View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories has re-constituted seven key committees of its Board with effect from July 5, 2025, via a circular resolution passed on July 4, 2025. The committees include the Audit Committee, Nomination & Remuneration Committee, Stakeholder Relationship Committee, Risk Management Committee, CSR Committee, Sub-Committee of Board, and Compensation Committee. Prabhat Khurana will chair the Audit Committee, while Rajinder Kumar Gupta will chair the NRC, Stakeholder Relationship, Risk Management, and Compensation Committees. Navrattan Munjal will chair the CSR Committee and Sub-Committee of the Board. The composition retains a mix of independent and non-independent directors across committees.

Likely market impact

This is a routine administrative reshuffle of board committee roles with no change in leadership at the company level. It is unlikely to have any material impact on the stock price or shareholder interests, as no new appointments, resignations, or governance concerns have been flagged.